Biography
Qing Liu is a Director of institute for foodbone pathogen harmfuless and management school of medical instrument and food engnieering and Professor at Univercity of Shanghai for Science and Technology, China
Abstract
Listeria monocytogenes (Lm) is a kind of food pathogenic bacteria with strong pathogenicity that has been shown previously to cause infection via the gastrointestinal (GI) tract. External pathogens can cause changes in gut microbiota, and such a change can promote or confer resistance to the infection of pathogenic bacteria. However, the changes in the microbiota during Lm through the GI tract and infect the body is unknown. Eight-week-old mice’s were inoculated orally with L. monocytogenes EGD-e, and portions of the liver, spleen and cecal contents were removed, homogenized and plated, and feces were collected on 0 day, first day and third day. After that, different concentrations of FMT were used to treat Lm infected mice. L. monocytogenes culture confirmed that the content of Lm in cecum after intragastric inoculation reached the highest level on first day, and then remained at a low level. The content of Lm in spleen and liver reached the highest level on third day. The percentage of the Proteobacteria spp, Bacteroidetes and Cyanobacteria on first day remained significantly higher than that of the 0 day (P<0.01), while the proportion of Lactobacillus and Staphylococcus on first day was significantly lower than that of the 0 day (P<0.01). Compared to first day, the Coprococcus, Blautia and Eubacterium increased significantly on third day. In addition, the mortality of infected mice was reduced by 28% after FMT treatment compared with PBS treatment. Finally, we showed that inoculated with EGD-e significantly altered the gut microbiome in mice in different times and the potential probiotics increased in infected mice like the Blautia may be developed as new probiotics to enhance resistance against L. monocytogenes infections. The gut microbiome of healthy mice can significantly reduce the mortality of infected mice by reducing the inflammatory response and rebuilding the dysbacteriosis.
Biography
Kennedy Adu-Twum has completed his MBChB program from the Kwame Nkrumah University, Faculty of Medicine, Ghana. He is a Junior Physician Health Staff at the Kumasi South Hospital of the Diagnosis Directorate of the hospital and has served for two years. He has published 13 papers in reputed journals and has been serving as an Editorial Member for many heaths.
Abstract
A claim on beta-glucans and maintenance of normal blood cholesterol concentrations has already been assessed with a favorable outcome. The main objective of this study was to assess the claim of beta-glucans from barley grain products lowering effect on low-density lipoprotein (LDL) and cholesterol among Ghanaian population. Total cholesterol and LDL-cholesterol are the endpoints measures for this study. Participants with elevated blood LDL-cholesterol concentration (≥3.8 mmol/L) were eligible for the intervention phase. The main study parameters were LDL- cholesterol and total cholesterol. Out of total 343 participants recruited, 20.7% (71/343) were diabetic while 8.75% (30/343) were pre-diabetic. Also, 63.64% (217/343) had high total cholesterol levels, 32.46% (111/343) had high levels of LDL and 27.57% (94/343) had high triglyceride. However, only participants with high LDL (111) were selected for the intervention phase. Many (43.59%) of the study participants were within the age range of 31-60 years. During the baseline survey, 16.16% of the participants were diabetic, during the two weeks follow up, 12.12% were diabetic and 7.46% during the four weeks follow up of daily administration of beta-glucans supplement. Also, the proportion of participants with high TCHOL dropped from 95.96% to 78.79% and slightly increased to 83.58% by follow-ups I and II respectively. The proportion of participants with high LDL dropped from a baseline of value of 95.96% to 60.61% and increased to 79.1% by follow-ups I and II respectively. Also, the proportion of participants with desirable HDL dropped from 95.96% at baseline to 71.72% and 37.31% by follow-ups I and II respectively. The proportion of participants with high TG at baseline was 34.34% and this has declined to 34.34% and increased slightly to 32.84% by follow-ups I and II respectively. Beta-glucans has significantly lowered blood cholesterol concentrations among Ghanaians.